OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs
Evgenia Koureta
Annals of Gastroenterology (2023)
Open Access | Times Cited: 4
Evgenia Koureta
Annals of Gastroenterology (2023)
Open Access | Times Cited: 4
Showing 4 citing articles:
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 4
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 4
